Clinical Trials
3
Active:0
Completed:2
Trial Phases
1 Phases
Phase 1:3
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 1
3 (100.0%)A Study Evaluating the Safety, Tolerance and Anti-tumor Activity of HBM1020 in Subjects With Advanced Solid Tumors
- First Posted Date
- 2023-04-21
- Last Posted Date
- 2023-04-21
- Lead Sponsor
- Harbour BioMed US, Inc.
- Target Recruit Count
- 50
- Registration Number
- NCT05824663
CLN-418 Study on Subjects With Advanced Solid Tumors
- First Posted Date
- 2022-04-01
- Last Posted Date
- 2025-04-25
- Lead Sponsor
- Harbour BioMed US, Inc.
- Target Recruit Count
- 108
- Registration Number
- NCT05306444
- Locations
- 🇺🇸
USC Norris Comprehensive Cancer Center, Los Angeles, California, United States
🇺🇸Florida Cancer Specialists, Sarasota, Florida, United States
🇺🇸Carolina BioOncology Institute - Cancer Research Centre, Huntersville, North Carolina, United States
A Study Evaluating the Safety, Tolerance and Anti-tumor Activity of a Study Drug in Subjects With Advanced Solid Tumors
- First Posted Date
- 2019-10-22
- Last Posted Date
- 2023-04-18
- Lead Sponsor
- Harbour BioMed US, Inc.
- Target Recruit Count
- 65
- Registration Number
- NCT04135261
- Locations
- 🇦🇺
St. George Private Hospital, 1 South Street, Kogarah, New South Wales, Australia
🇦🇺Macquarie University, 2 Technology Place, Macquarie, New South Wales, Australia
🇦🇺Monash Health, Monash Medical Centre, 246 Clayton Road, Clayton, Victoria, Australia
News
No news found